HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

7- beta- galactopyranosyloxycoumarin- 4- acetic acid

structure given in first source

Also Known As:

GPOCA

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        7-beta-galactopyranosyloxycoumarin-4-acetic acid: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        7-beta-galactopyranosyloxycoumarin-4-acetic acid: 1
Carbohydrates: 22023
- Sugars: 11126
  - Monosaccharides: 889
    - Hexoses: 549
      - Galactose: 3212
        7-beta-galactopyranosyloxycoumarin-4-acetic acid: 1

Experts

1.	Arias, José L: 1 article (09/2009)
2.	Couvreur, Patrick: 1 article (09/2009)
3.	Reddy, L Harivardhan: 1 article (09/2009)

Related Diseases

1.

Neoplasms (Cancer)

09/01/2009 - "Following intravenous administration into the mice bearing L1210 wt subcutaneous tumor, the GPOCA nanoparticles displayed significantly greater anticancer activity compared to free gemcitabine; this has been additionally confirmed by histology and immunohistochemistry studies, suggesting the potential of GPOCA for the efficient treatment of cancer."
09/01/2009 - "The cytotoxicity studies performed on L1210 tumor cells revealed a similar anticancer activity of the gemcitabine-loaded POCA (GPOCA) nanoparticle as free gemcitabine. "

Related Drugs and Biologics

1.	Gemcitabine
2.	ethyl 2- (5- (4- chlorophenyl)pentyl)oxiran- 2- carboxylate (POCA)

Related Therapies and Procedures

1.	Intravenous Administration